Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study

- Parkinson's Disease
- Completed

Study Title: A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.

Teva Identifier: TVP - 1012/133a

ClinicalTrials.gov Identifier: NCT00203125

Study Status: Completed

Trial Condition(s): Parkinson's Disease

Interventions: Drug: rasagiline mesylate | Other: tyramine

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: Child, Adult, Older Adult

Trial Duration: 10/01/2000 - 01/01/2003

Phase: Phase 3

Study Type

Interventional